Evidence map›Paper›PMID 39213087›Full record

ReviewJournal of Huntington's disease2024

Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models.

Jenna Hanrahan, Drew P Locke, Lindsay S Cahill

Abstract readReview
In one paragraph

Review in Journal of Huntington's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Imaging the enteric nervous system.Frontiers in neuroanatomy · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jenna HanrahanDepartment of Chemistry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Drew P LockeDepartment of Chemistry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Lindsay S CahillDepartment of Chemistry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural magnetic resonance imaging (MRI) is a powerful tool to visualize 3D neuroanatomy and assess pathology and disease progression in neurodegenerative disorders such as Huntington's disease (HD). The development of mouse models of HD that reproduce many of the psychiatric, motor and cognitive impairments observed in human HD has improved our understanding of the disease and provided opportunities for testing novel therapies. Similar to the clinical scenario, MRI of mouse models of HD demonstrates onset and progression of brain pathology. Here, we provided an overview of the articles that used structural MRI in mouse models of HD to date, highlighting the differences between studies and models and describing gaps in the current state of knowledge and recommendations for future studies.

Indexed as

BrainDisease Models, AnimalHuntington DiseaseMagnetic Resonance ImagingAnimalsHumansMiceBrain structureHuntington’s diseasemagnetic resonance imagingmouse modelsneuroanatomy

Identifiers

PMID39213087
PMCPMC11494634

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.